Coronary flow reserve (CFR) assessment by transthoracic ultrasound of the left anterior descending (LAD) artery during dipyridamole stress echocardiography has been shown to predict prognosis in large unselected populations. Low values of CFR are strongly correlated with significant stenosis of the LAD; aim of the present study was to assess the prognostic impact of CFR in patients recovering from an acute coronary syndrome (ACS) with proven absence of LAD disease.
Introduction
Dipyridamole stress echocardiography with measurement of coronary flow on the left anterior descending (LAD) artery is a reliable non-invasive method for the assessment of coronary flow reserve (CFR). 1 -3 The impairment of ultrasound-assessed CFR predicts prognosis and cardiac events in large unselected populations of chronic patients. 4, 5 Such prognostic value seems to be related, at least in a relevant number of patients, to the presence of proximal LAD disease directly decreasing regional blood supply; however, coronary perfusion strongly depends on downstream responses, diffuse microvascular damage, myocardial viability, and endothelial dysfunction. CFR has been shown to decrease in patients with multiple atherosclerotic risk factors even in the absence of LAD stenosis. 6 -9 Aim of the present study was to explore the prognostic significance of ultrasound-assessed CFR in a selected population of patients without LAD disease soon after an acute coronary syndrome (ACS).
Patients and methods

Patient population and study protocol
Study population was derived from a total cohort of 325 consecutive patients admitted to a tertiary coronary care unit with a diagnosis of ACS defined as unstable angina, inferior, or lateral ST-elevation myocardial infarction (STEMI) according to current guidelines. 10, 11 From this cohort, a group of 152 patients who were free from LAD disease (LAD stenosis ,50% at coronary angiogram) were enrolled and subsequently followed for events. This study did not include patients with non-STEMI and subjects with apical wall motion abnormalities at rest; this choice was meant to minimize the possibility of enrolling patients with the LAD as the culprit lesion for recent necrosis and patients with acute microvascular damage in the LAD territory. Other exclusion criteria were the presence of electrocardiographic evidence of anterior ischaemia (ST-segment elevation of .1 mm in leads V1 -V4), a history of coronary artery bypass grafting (CABG), hypertrophic or dilated cardiomyopathy, atrial fibrillation, and severe obstructive pulmonary disease.
Patients were treated as clinically indicated, including thrombolysis and primary PCI. Medical treatment during hospital stay complied with contemporary guidelines. All patients received dual antiplatelet therapy, anticoagulants, beta-blockers, and ACE-inhibitors when tolerated; nitrates were used as clinically indicated, and withdrawn 12 h before the echocardiographic study. Patient history was collected; smoke stands for 'current smoker' in tables.
All patients underwent high-dose dipyridamole stress echocardiography after they had been asymptomatic for at least 72 h. In patients who received primary or facilitated PCI for STEMI, data from initial coronary angiography were used, and CFR assessment was performed 72 h thereafter; in all remaining patients (those who did not undergo immediate angiography), coronary angiography was carried out within 48 h from the echocardiographic study.
All patients gave written informed consent to stress echocardiography and coronary angiography. The study was Board approved and was conducted according to the Declaration of Helsinki.
Echocardiographic protocol
Transthoracic stress echocardiography was performed using a commercially available ultrasound machine (Vivid System 7, GE/Vingmed, Milwaukee, WI, USA). A high-dose dipyridamole stress protocol (up to 0.84 mg/kg in 6 min) was performed during ECG monitoring; blood pressure and heart rate were recorded every 2 min.
Left ventricular volumes and ejection fraction were quantified before and after stress by means of the Simpson's biplane formula.
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A 16-segment model was used for categorization of segmental function according to current recommendations.
CFR was performed during the standard stress echo with semisimultaneous imaging of wall motion and LAD flow, as previously described. 13 Coronary flow in the mid-distal LAD was searched with colour guidance in a modified apical short axis or, alternatively, from a modified apical two-chamber view.
Coronary flow tracings were obtained positioning a sample volume on the colour signal in the LAD. Flow velocities were measured at least twice during the study, at rest, and at peak stress; values were averaged from three cardiac cycles. CFR was defined as the ratio between peak LAD velocity after stress and peak resting velocity.
Fifteen patients with inadequate Doppler signal received an intravenous contrast agent (Levovist, Schering AG, Berlin) at a concentration of 300 mg/ml with an infusion rate of 1 ml/min.
All examinations were recorded on digital support and then interpreted offline by an experienced investigator (L.A.) who was blinded to patient clinical data and angiograms.
Coronary angiography
Coronary angiography was performed following current recommendations, using the Seldinger technique with a femoral or radial approach. Angiographic extent of coronary artery disease (CAD) was quantified in an offline reading by an experienced observer (V.M.) who was blinded to echocardiographic findings and to clinical data. LAD disease was defined by a narrowing of ≥50% of the lumen diameter in at least one projection; all patients with LAD stenosis ≥50% were excluded from the present analysis. Coherently, one-vessel and twovessel CAD were defined by the presence of a ≥50% stenosis in either the right coronary artery (RCA), the circumflex artery, or both.
Follow-up data
Data for vital status and clinical events were collected using prescheduled outpatient visits and/or telephone contacts with the patients, their relatives, caregivers, or referring physicians. Full medication history during follow-up was not available for all patients, so we decided to exclude medications from the multivariable prognostic model. Major adverse cardiac events (MACE) were defined as: death from any cause, non-fatal myocardial infarction, or symptom-driven cardiac revascularization (CABG or PCI).
Statistical analysis
Continuous variables are expressed as means + SDs, unless otherwise stated. Data were analyzed using the IBM SPSS Version 19 Package (IBM Corp., Armonk, NY, USA) and R (R 2.15.2-Open Source, The R Foundation for Statistical Computing).
The Mann-Whitney U-test was used for comparison of continuous variables; frequencies of discrete variables were compared using Chi-Square.
Receiver-operating characteristic (ROC) curve analysis was used to explore optimal CFR cut points with respect to the prediction of MACE; C-statistic was calculated and reported with 95% confidence interval (CI). Sensitivity and specificity analysis with 95% CI was performed to identify the optimal CFR cutoff value by means of Youden's J statistic.
Effects of individual variables on overall event-free survival were analyzed by means of Cox regression; multivariable forward stepwise Cox regression was performed with variables found to be significant in the univariable analysis; a significance of ,0.05 was required for a variable to enter the model, whereas a value above 0.1 was adopted for exclusion; hazard ratios and 95% CIs were estimated for each variable; Harrell's C-statistic was calculated for the final model. Kaplan-Meier curves were built grouping patients based on CFR values above or below the cut point identified by ROC analysis, and by smoking status; the log-rank test was used to compare survival between groups. A P-value of ,0.05 was considered statistically significant.
Results
Out of an initial cohort of 325 patients, 173 were excluded from the analysis: 10 (3%) because of inadequate acoustic window, 25 (8%) because of clinical instability, and 138 (42%) because of the presence of LAD disease. The remaining 152 patients (73% males) represented the study population.
Acute management was as follows: 57 subjects (50% of patients with STEMI) underwent primary angioplasty on the culprit vessel [RCA or circumflex branch of the left coronary (Cx)]. Fifty-two subjects (48% of patients with STEMI) had been treated with firstline thrombolysis; 25 of them were subsequently treated with facilitated PCI after admission. All patients with unstable angina (n ¼ 43) were initially treated conservatively.
Demographics and patient characteristics are shown in Table 1 . In our study, 111 subjects (73%) had angiographic evidence of obstructive CAD, whereas 41 patients (27%) showed no significant coronary atherosclerosis. Most patients had normal or nearnormal resting left-ventricular ejection fraction, and mean values of resting WMSI were relatively preserved. However, only 73 patients had normal resting regional wall motion at study echo, whereas 79 showed wall motion abnormalities in at least 1 myocardial segment. Prevalence of diabetes mellitus was 16%.
No severe adverse events were observed following dipyridamole administration. Eleven patients developed chest pain that readily responded to aminophylline. Contrast infusion was needed to improve LAD Doppler signal in 15 patients (9.8%).
Mean CFR values were above traditional cutoffs of normality, a finding in line with the per protocol absence of LAD disease; only 6 out of 152 patients (4%) had CFR values below 2, and 5 of them were diabetics.
During a mean follow-up of 29 + 12 months, 22 patients developed MACEs, subdivided as follows: 4 deaths, 11 non-fatal MI, and 7 PCI procedures. Comparison between patients who experienced MACEs and those who did not is shown in Table 2 . The two groups were significantly different in terms of age, diabetes, number of diseased vessels at coronary angiography, and CFR. No differences were found in terms of relevant medications on testing (not  shown in table) .
ROC curve analysis was performed to identify optimal CFR cutoffs for the prediction of MACE ( Figure 1) ; censored data were assumed as 'no event'. The C-statistic (area under the curve) for CFR was 0.864 (95% CI: 0.777 -0.952). Optimal cutoff was determined by sensitivity/specificity analysis ( Table 3 ) with calculation of Youden's J index: a cutoff CFR value of ,2.25 had a sensitivity of 86% (95% CI: 65.1-97.1%) and a specificity of 80% (95% CI: 72.1-86.5%) in the prediction of MACE (Youden's J ¼ 0.66). The latter value was subsequently employed in the univariate and multivariable regression analyses. Table 4 shows the results of univariate and multivariable regression analysis using the Cox proportional hazards model. Initial univariable analysis also included the following variables, not shown in table: D-WMSI, D-left ventricular ejection fraction, anti-ischaemic treatment on testing, and family history of CAD (P ¼ NS for all). Significant variables at univariable analysis were studied in a forward stepwise multivariable Cox model (Table 3 right panel), which showed significant independent prediction only for smoking status, number of stenotic coronaries at angiography, and CFR values below 2.25; age was retained in the model but found to be non-significant at multivariable regression. The global Harrell's C-statistic for the final model, including age, smoke, CFR below 2.25, and number of diseased vessels equalled 0.920 (95% CI: 0.875-0.972). As a comparison, prediction model for CFR ,2.25 only had a C-value of 0.830 (95% CI: 0.734-0.920).
Kaplan-Meier survival curves were plotted using the same cutoff ( Figure 2, upper panel) ; the log-rank test demonstrated significant difference between groups (x 2 for log rank ¼ 34.3; P , 0.001). Another Kaplan -Meier analysis was performed categorizing patients into four groups depending on CFR values (above or below 2.25) and smoking status, according to the results of multivariable Cox analysis ( Figure 2, lower panel) ; log-rank test had increased significance when compared with the previous analysis (x 2 for log rank ¼ 60,7; P , 0.0001).
Discussion
In this study, we demonstrate the prognostic value of ultrasound-assessed CFR in subjects with ACS and with proven absence of left-anterior descending artery disease. Such prognostic value was independent of more traditional clinical and instrumental risk factors and appeared to be evident at CFR values higher than current established cutoffs.
Patients recovering from a non-complicated ACS carry the highest risk of subsequent recurring cardiac events. Long-term risk stratification, as also pointed out in recent guidelines, relies on clinical characteristics, risk factors, anatomical severity of coronary disease, resting left ventricular systolic function, and evidence of ischaemia at early follow-up stress testing. 10, 11 Ultrasound-assessed CFR is a validated, reproducible, and noninvasive means for the evaluation of perfusion reserve during a standard stress echo examination; it increases the diagnostic accuracy of standard wall motion analysis in the diagnosis of LAD stenosis 13 and entails strong prognostic significance in large populations of stable patients with known or suspected ischaemic heart disease, independent of other risk factors. 6 -9,14,15 This prognostic value has traditionally been ascribed to two mechanisms. First, to the sensitivity of CFR values to the presence and extent of proximal LAD disease: very low CFR values (,2) almost invariably implicate some degree of proximal or mid-LAD stenosis that in turn generally confers a worse prognostic outlook to the patient. Second, coronary reserve appears to decrease in the presence of a number of factors independent of LAD disease, i.e. traditional atherosclerotic risk factors, diabetes mellitus, distal microvascular and endothelial dysfunction, left ventricular hypertrophy, and local inflammation. 6 -9,16 In this respect, our study strengthens the concept that the prognostic spectrum of CFR values is continuous, in that no single cut point can be identified in the general population, but increasing impairment reflects progressively worse outcomes. 5 This seems particularly true when comparing our findings in a selected population free of LAD disease with previous reports: proximal LAD disease, besides playing an independent prognostic role in established CAD, most probably decreases the impact of clinical and Dipyridamole coronary flow reserve stratifies prognosis in acute coronary syndrome non-macrovascular aspects on CFR values. Therefore, it seems sound that, in patients with very high expected cardiovascular risk, but without LAD involvement, reduced CFR entails an important clinical meaning already at values higher than commonly accepted cutoffs (i.e. ,2.25). Conversely, a relatively low longterm risk of recurrent events can be expected in patients who show a completely preserved CFR, despite a recent ACS; the latter bottom line has strong practical clinical implications in managing patients after acute ischaemia and also reconfirms some previous observations in chronic patients. 4 To our knowledge, only one previous small study has demonstrated a prognostic value of CFR in patients with CAD not involving the LAD branch; 17 however, besides being performed in chronic elective patients, the latter study adopted transoesophageal proximal LAD sampling with lower doses of dipyridamole. In our multivariable analysis, CFR seemed to outperform all other clinical and instrumental risk factors, and residual significance beyond CFR could only be demonstrated for ongoing smoking habit and extent of CAD. These results seem reasonable from a pathophysiological standpoint; even though it could seem surprising that diabetes does not independently predict events in this population, a previous work already suggested this 'neutralization' of the prognostic value of diabetes when taking into account CFR. 18 It is straightforward to think that an early impairment in myocardial 'perfusion reserve' after an acute event may translate into a bad prognosis; several studies have explored the clinical significance of quantitative myocardial perfusion reserve following an acute myocardial infarction, using either invasive methods (i.e. flow reserve quantification during cathetherization) 19, 20 or radionuclide scan. 21, 22 A reduced perfusion reserve has been advocated as a risk factor for adverse left ventricular remodelling, 20 and an important correlation between abnormal glucose metabolism and decreased CFR has been observed. 23 However, even in the 
Study limitations
The present study was carried out in a single, highly dedicated tertiary centre with extensive experience in stress echocardiography and CFR, and only a very small proportion of patients was deemed unsuitable for technical reasons (,5%); these observations may not be applicable to real-world settings, especially in small-volume centres. Moreover, we must acknowledge that both length and methods of follow-up were heterogeneous among patients, leading to censoring that might have affected diagnostic yield. The choice to not include non-STEMI patients may represent in some way a limitation; however, in our opinion, this does not restrict the applicability of our findings in the population of ACS patients without LAD disease.
Sampling of coronary flow only involved the LAD, and not all three main coronary branches; however, besides evident technical difficulties in obtaining RCA and Cx flow readings in Caucasian, often overweight subjects, one of our aims was to focus on the significance of CFR in a disease-free LAD.
A large majority of the patients were on one or more antiischaemic drugs upon testing; of course, this was related to the characteristics of the population, i.e. patients recovering from an ACS; in our opinion, this does not reduce or alter the clinical meaning of our findings, given that previous analyses already suggested that the predictivity of CFR in chronic patients seems to be unaffected from drug therapy. 25 
Conclusions
In the present paper, we demonstrated the prognostic value of dipyridamole CFR assessed early after an ACS in patients without LAD involvement at coronary angiogram. Significant risk prediction occurred at values higher than conventional CFR cutoffs. We believe that our findings, albeit preliminary and obtained in a relatively small population, clearly promote the role of echo-CFR in the stratification of high-risk patients, independent of discrete lesions in the LAD, and reflect systemic atherosclerotic and endothelial damage.
